Economic Situation and Hot Spots of Corporate Organizational Learning
Release time:
2020-08-17
Company organized to learn about the economic situation and hot spots
News from our newspaper 7# On the morning of May 18 , taking the opportunity of the work analysis meeting in the first half of 2020 , the group company invited Lan Jianping, president of Zhejiang Institute of Industry and Information Technology and secretary general of Zhejiang Industrial Economic Advisory Committee of Chinese Academy of Sciences, for the participating management cadres to do "current economic situation and digital economy, industrial chain and other hot spot analysis" special lecture.
The global economy in the first half of 2020was in an unprecedentedly complex situation due to the impact of the new crown epidemic. As far as Zhejiang Province is concerned, since the second quarter, the province's economy has shown a trend of "monthly recovery and V rebound". Compared with the first quarter, no matter from the perspective of micro-enterprise development expectations or from the perspective of macro-index operation, the market Positive factors continue to increase. In view of this situation, Lan Jianping analyzed the overall global situation in combination with the changes of PMI index (Purchasing Managers' Index ), primary product price index and energy index in the first half of the year; based on the changes in China's Purchasing Managers Index (PMI ) and Industrial Producer Price Index (PPI ) in the first half of the year, the domestic capital market, export trade, exchange rate and other economic indicators are analyzed. Lan Jianping focused on the economic trend of Zhejiang Province in the first half of the year, and came to the conclusion that the domestic and foreign markets are picking up simultaneously, the overall expectations of enterprises have improved, the main economic indicators are positive, and the positive changes in the market tend to increase. At the same time, he pointed out that the leading industry is generally stable and the supporting pattern is not stable.
In view of the important role played by the digital economy in the prevention and control of the new crown epidemic, Lan Jianping put forward the view that "'number' of 'Zhe' is the pioneer practice of Zhejiang's economy and the 'window' exploration of socialist modernization with Chinese characteristics. He believes that, combined with the changes in the world's political and economic landscape after the epidemic, enterprises can only focus on the "six new", in order to turn pressure into power, "crisis" into "machine". That is, to accelerate the breakthrough of "new technologies" in industries with collaborative innovation; Focus on the innovation of business mode and cultivate and strengthen "new industries"; Focus on the digital transformation of industries and cultivate and develop "new manufacturing"; Focus on promoting digital empowerment and deepening and expanding "new applications"; Focus on infrastructure support and advance layout of "new facilities"; Focus on the development of institutional mechanisms and focus on building a "new system". In the second half of 2020, the impact of the global economic downturn caused by the new crown epidemic still exists, and "steady growth" still faces greater challenges. It is expected that the economy will show a trend of "low start, V rebound, slower growth rate, and stable pressure" throughout the year. It is necessary to pay close attention to the new trends of changes in domestic and foreign markets, the new direction of technological progress and development, and the new modes of enterprises and industries, actively take the initiative to forge ahead, change from passive to active.
Lan Jianping also analyzed and elaborated on current hot concepts and hot issues such as the industrial chain.Chen Yan, secretary of the party group of Jinhua Federation of Industry and Commerce, Xu Guoxian, vice chairman, and more than a dozen Jinhua entrepreneurs also attended the special study. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page